Phase I and pharmacokinetic trial of PTC299 in pediatric patients with refractory or recurrent central nervous system tumors: a PBTC study

Roger J. Packer*, Brian R. Rood, David C. Turner, Clinton F. Stewart, Michael Fisher, Christopher Smith, Tina Young-Pouissant, Stewart Goldman, Rishi Lulla, Anu Banerjee, Ian Pollack, Larry Kun, Arzu Onar-Thomas, Shengjie Wu, James M. Boyett, Maryam Fouladi

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

20 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I and pharmacokinetic trial of PTC299 in pediatric patients with refractory or recurrent central nervous system tumors: a PBTC study'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience

Biochemistry, Genetics and Molecular Biology